Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells
- 5 February 2007
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 26 (33), 4877-4881
- https://doi.org/10.1038/sj.onc.1210266
Abstract
Acquisition of drug resistance is one of the main obstacles encountered in cancer chemotherapy. Overexpression of multi-drug resistance 1 (MDR1) gene and its protein product P-glycoprotein, accompanied with a decrease in doxorubicin accumulation level, was observed in doxorubicin-resistant R-HepG2 cells, a subline derived by selection of human hepatocellular carcinoma HepG2 cells with doxorubicin. In addition, Northern-blot analysis revealed an eight fold upregulation of the imprinted H19 mRNA in R-HepG2 cells. H19 knockdown by transfection with antisense H19 oligonucleotides suppressed the MDR1/P-glycoprotein expression, increased the cellular doxorubicin accumulation level and sensitized doxorubicin toxicity in both HepG2 parent cells and R-HepG2 cells. Results from methylation-specific polymerase chain reaction analysis indicated that the MDR1 gene promoter was hypomethylated in R-HepG2 cells. Antisense H19 oligonucleotides transfection induced a marked increase in the percentage of MDR1 promoter methylation and decrease in MDR1 expression in R-HepG2 cells. Thus, the H19 gene is believed to induce P-glycoprotein expression and MDR1-associated drug resistance at least in liver cancer cells through regulation of MDR1 promoter methylation.Keywords
This publication has 10 references indexed in Scilit:
- CpG Hypermethylation of MDR1 Gene Contributes to the Pathogenesis and Progression of Human Prostate CancerCancer Research, 2004
- Developmentally regulated functions of the H19 differentially methylated domainHuman Molecular Genetics, 2003
- Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cellsCarcinogenesis: Integrative Cancer Research, 2002
- Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNAOncogene, 2002
- Non–coding RNA genes and the modern RNA worldNature Reviews Genetics, 2001
- Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cellsJBIC Journal of Biological Inorganic Chemistry, 1999
- Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid LeukemiasBlood, 1998
- Tumour-suppressor activity of H19 RNANature, 1993
- A fine-structure deletion map of human chromosome 11p: Analysis of J1 series hybridsSomatic Cell and Molecular Genetics, 1989
- Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes.Proceedings of the National Academy of Sciences of the United States of America, 1984